ABSTRACT The genus Streptomyces is known for its secondary metabolite biosynthetic capacities. We report here the draft genome sequence of the most extensively studied -poly-L-lysine producer, Streptomyces albulus NBRC14147. Bioinformatic analysis of the 9.6-Mb chromosome identified a large number of secondary metabolite biosynthetic gene clusters.
coding genes, including genes organizing the canonical lysine biosynthetic diaminopimelate pathway, which could be involved in -PL biosynthesis. Analysis of the chromosome using antiSMASH 4.0 (15) predicted 37 biosynthetic gene clusters (BGCs) for secondary metabolite production, implying that the strain could possess considerable secondary metabolite biosynthetic potential. The NBRC14147 chromosome appears to harbor several BGCs for uncharacterized nonribosomal peptides and polyketides. The draft genome sequence will allow us not only to genetically and metabolically engineer this valuable strain to further improve -PL production but also to explore uncharacterized natural product drug leads.
Data availability. This whole-genome shotgun project has been deposited in DDBJ/EMBL/GenBank under the accession no. BHXC00000000. The version described in this paper is the first version, BHXC01000000. The raw sequence reads have been deposited in DDBJ/EMBL/GenBank under the accession no. DRR161053.
